A highly sensitive LC–MS–MS assay for analysis of midazolam and its major metabolite in human plasma: Applications to drug metabolism
- 5 August 2005
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B
- Vol. 822 (1-2), 27-32
- https://doi.org/10.1016/j.jchromb.2005.05.011
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Determination of picogram levels of midazolam, and 1- and 4-hydroxymidazolam in human plasma by gas chromatography–negative chemical ionization–mass spectrometryJournal of Chromatography B, 2004
- Pharmacogenetics of the major polymorphic metabolizing enzymesFundamental & Clinical Pharmacology, 2003
- Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probesPharmacogenetics, 2000
- CYTOCHROME P-450 3A4: Regulation and Role in Drug MetabolismAnnual Review of Pharmacology and Toxicology, 1999
- Interaction with P-glycoprotein and transport of erythromycin, midazolam and ketoconazole in Caco-2 cellsEuropean Journal of Pharmacology, 1998
- Sensitive assay for midazolam and its metabolite 1′-hydroxymidazolam in human plasma by capillary high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1998
- Analysis of Midazolam and Metabolites in Plasma by High-Performance Liquid Chromatography: Probe of CYP3ATherapeutic Drug Monitoring, 1998
- IN VITRO AND IN VIVO DRUG INTERACTIONS INVOLVING HUMAN CYP3AAnnual Review of Pharmacology and Toxicology, 1998
- Midazolam: A review of therapeutic uses and toxicityThe Journal of Emergency Medicine, 1997
- Simultaneous determination of midazolam and its metabolites 1-hydroxymidazolam and 4-hydroxymidazolam in human serum using gas chromatography–mass spectrometryJournal of Chromatography B: Biomedical Sciences and Applications, 1997